Deals & Capital Markets
BioMarin Bets $4.8 Billion on Amicus to Create Rare Disease Powerhouse
Dec 19, 2025
You're signed outSign in or to get full access.
BIOMARIN PHARMACEUTICAL (BMRN) Earnings Call Transcripts
Browse quarterly earnings call transcripts for BIOMARIN PHARMACEUTICAL.
Q3 2025
Oct 27, 2025
Q2 2025
Aug 4, 2025
Q1 2025
May 1, 2025
Q4 2024
Feb 19, 2025
Q2 2021
Jul 28, 2021
Q1 2021
Apr 29, 2021
Q4 2020
Feb 25, 2021
Q3 2020
Nov 5, 2020
Q2 2020
Aug 4, 2020